Cyrolipolysis + Subcision for Cellulite
Trial Summary
Will I have to stop taking my current medications?
If you are currently taking antiplatelet or anticoagulant medications, you will need to stop as they are not allowed in this trial. For other medications, the protocol does not specify, so it's best to discuss with the trial team.
What data supports the effectiveness of the treatment Cyrolipolysis + Subcision for Cellulite?
Research shows that cryolipolysis is effective in reducing fat layers and improving body contouring, while subcision is useful for treating advanced cellulite. Combining these treatments may enhance their effectiveness in addressing cellulite by targeting both fat reduction and skin texture improvement.12345
Is the combination of Cryolipolysis and Subcision safe for treating cellulite?
Cryolipolysis is generally considered safe, but it can have side effects like skin changes, frostbite, and rare cases of increased fat in treated areas. Temporary side effects usually resolve on their own. There is no specific safety data on combining Cryolipolysis with Subcision for cellulite.16789
How does the treatment of Cryolipolysis + Subcision for cellulite differ from other treatments?
This treatment is unique because it combines cryolipolysis, which uses controlled cooling to reduce fat cells, with subcision, a technique that releases fibrous bands under the skin to improve the appearance of cellulite. This combination targets both fat reduction and the structural causes of cellulite, offering a dual approach that is different from other non-invasive body contouring methods.15101112
What is the purpose of this trial?
This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus a combination of cryolipolysis and surgical subcision for the treatment of cellulite. The treatment sites are both outer thighs. One outer thigh will be randomized to receive one treatment of cryolipolysis, while the contralateral thigh will be assigned to receive the combination cryolipolysis plus surgical subcision. A live rating by a blinded dermatologist will evaluate the treatment and control areas using a cellulite severity scale at week 0 (before treatment) and at the 3-month follow up visit.
Research Team
Murad Alam, MD
Principal Investigator
Northwestern University
Eligibility Criteria
Healthy women aged 18-65 with noticeable cellulite on both thighs, who can give informed consent. Excluded are those pregnant or breastfeeding, allergic to certain antibiotics or local anesthetics, taking blood thinners, have a coagulation disorder, abnormal scarring history, active skin disease/infection in the area, or cold-induced diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either cryolipolysis or a combination of cryolipolysis and surgical subcision on the outer thighs
Follow-up
Participants are monitored for changes in cellulite severity using a live rating by a blinded dermatologist
Treatment Details
Interventions
- Cryolipolysis
- Subcision
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Zeltiq Aesthetics
Industry Sponsor